ZHAO Yourong, et al. Clinical study on treatment of severe hepatitis by plasma exchange. [J]. Journal of Chongqing Medical University (5):672-674(2004)
ZHAO Yourong, et al. Clinical study on treatment of severe hepatitis by plasma exchange. [J]. Journal of Chongqing Medical University (5):672-674(2004) DOI: 10.13406/j.cnki.cyxb.2004.05.033.
Clinical study on treatment of severe hepatitis by plasma exchange
Objective:To evaluate the efficacy and mechanism of plasma exchange (PE) in the treatment of severe hepatitis.Methods:139 patients with severe hepatitis were divided into treated and control groups.Both groups were treated with the same routine therapies
but the treated group received the PE.The liver function and serum ammonia
concentration of serum HBV-DNA spectrum were detected before and after treatment with PE.The efficacy and safety were evaluated with clinical parameters respectively.Results:Liver function was significantly improved after PE therapy.There was significant decrease in concentration of serum ammonia from 127.91±57.33 (ixnol/L) to 81.51±40.20 (μmol/L) P <0.001
concentration of serum HBV-DNA(Log10copy/ml) from 5.72±1.39 to 4.13±1.35( P <0.005).Compared with the control group
there was significantly increased cure and improved rate in the treated group [67.03(61/91) vs 50.0 %(24/48)]( P <0.05).The response rates of severe hepatitis in early stage
middle stage were 95 %(19/20) vs 72.27%(8/11) ( P <0.05) and 82.50 %(32/39) vs 57.14 %(12/21) respectively ( P <0.05).Conclusion:PE treatment of severe hepatitis is effective
Clinical effect of plasma exchange combined with double plasma molecular adsorption system in artificial liver support therapy for patients with liver failure and hyperbilirubinemia
Diabetic demyelinating neuropathy:a report of five cases
The therapeutic effects comparison between plasma exchange and hemoperfusion in treating pattents of thronic hepatitis with hyperbilirubinemia
Progress in clinical treatment of severe gestational hypertriglyceridemia
Guiding significance of model for end-stage liver disease score on choosing artificial liver in patients with HBV-related liver failure
Related Author
Dai Mei
Shen Youshu
Luo Yawen
Yang Ping
Liu Kangyan
Wang Zhangqin
Zhao Fei
Chen Zongqian
Related Institution
Department of Infectious Diseases,The Affiliated Hospital of Zunyi Medical University
Department of Neurology, College of Clinical Medicine, Chongqing Medical University
重庆医科大学临床学院神经内科
Department of Infection,the Second Affiliated Hospital,Chongqing Medial University
Department of Endocrinology,Key Laboratory of Endocrinology of National Health Commission,Peking Union Medical College Hospital,Peking Union Medical College and Chinese Academy of Medical Sciences